GigaGen Enters COVID-19 Field

GigaGen Enters COVID-19 Field

In a collaboration with Access Biologicals, GigaGen is now recruiting donors who have convalesced from COVID-19. GigaGen will begin developing a recombinant polyclonal antibody therapy for the treatment of COVID-19. The therapy known as rCIG (recombinant...

Access Biologicals Products Now Available through Grifols Bio Supplies! Explore the Expanding Product Portfolio at www.biosuppliesproducts.com

X